Articles by Heidi M. Mansour - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Heidi M. Mansour

Heidi M. Mansour


Heidi M. Mansour, Ph.D., R.Ph.
Assistant Professor of Pharmaceutics & Drug Delivery, UK College of Pharmacy
Faculty Associate, UK Center of Membrane Sciences

Dr. Mansour currently holds faculty appointments and graduate appointments at the University of Kentucky (UK) College of Pharmacy, is a graduate faculty member at the University of North Carolina-Chapel Hill (UNC-Chapel Hill), and faculty associate of the UK Membrane Center. She is a faculty mentor in the UK Engineered Bioactive Interfaces and Devices Program funded through the National Science Foundation Integrative Graduate Education Research Training (NSF IGERT) Program and the NSF Research Education for Undergraduates (NSF REU) Training Program joint with the UK College of Engineering. She is also a faculty mentor in the National Cancer Institute-Cancer Nanotechnology Training Center (NCI-CNTC).

Articles
Sustained-Release Injectable Drug Delivery
November 1, 2010

A review on the current status of long-acting injectables, including commercially marketed products. This article is part of a special Drug Delivery issue.

It's Only Natural: Using Polymers in Drug Delivery
January 2, 2009

A book explains the many pharmaceutical applications of polymers from natural sources.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here